Geode Capital Management
ARLZ

Geode Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Geode Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,175
Closed -$64K – 4126
2017
Q3 		$64K Hold
28,175
– – ﹤0.01% 3902
2017
Q2 		$38K Sell
28,175
-7,640
-21% -$11K ﹤0.01% 3993
2017
Q1 		$76K Buy
35,815
+5,892
+20% +$22.1K ﹤0.01% 3879
2016
Q4 		$131K Buy
29,923
+692
+2% +$3.29K ﹤0.01% 3733
2016
Q3 		$141K Sell
29,231
-6,913
-19% -$31.5K ﹤0.01% 3709
2016
Q2 		$119K Sell
36,144
-41,106
-53% -$155K ﹤0.01% 3755
2016
Q1 		$273 Buy
+77,250
New +$398K ﹤0.01% 3517

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return

Geode Capital Management's ARLZ Position: Q4 2017 in Review

Geode Capital Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2017, closing a stake of 28,175 shares — an estimated $64K sold.

Geode Capital Management first reported a position in ARLZ in Q1 2016 and held it in 7 quarters. The position peaked at $141K in Q3 2016. 63 funds tracked by Wall St. Rank hold ARLZ as of Q4 2017.

  • Geode Capital Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q4 2017 after selling out during the quarter.
  • Geode Capital Management sold 28,175 Aralez Pharmaceuticals Inc. shares in Q4 2017, an estimated $64K.
  • Geode Capital Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 7 quarters.
  • Geode Capital Management's Aralez Pharmaceuticals Inc. position peaked at $141K in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2017.

Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.